A diabetes drug has been recalled because it contains high levels of cancer-causing agent
Indian pharmaceutical company Marksans Pharma Limited is recalling Metformin Hydrochloride Extended-Release Tablets because its levels of NDMA, a “probable human carcinogen,” were higher than the acceptable daily intake limit, according to an FDA recall.